title: NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation.
abstract: MicroRNAs regulate post-transcriptomic landscape in many tumors including renal cell carcinoma. We have recently shown significantly increased expression of miR-21 in renal tumors and that this miRNA contributes to the proliferation of renal cancer cells in culture. However, the mechanism by which miR-21 regulates renal cancer cell proliferation is poorly understood. Addiction to constitutive NFκB activity is hallmark of many cancers including renal cancer. Using miR-21 Sponge in renal cancer cells to block endogenous function of miR-21, we show inhibition of phosphorylation of p65 subunit of NFκB, IKKβ and IκB, which results in attenuation of NFκB transcriptional activity. Subtle reduction in the tumor suppressor PTEN has been linked to various malignancies. We showed previously that miR-21 targeted PTEN in renal cancer cells. Inhibition of PTEN by siRNAs restored miR-21 Sponge-induced suppression of phosphorylation of p65, IKKβ, IκB and NFκB transcriptional activity along with reversal of miR-21 Sponge-reduced phosphorylation of Akt. Expression of constitutively active Akt protected against miR-21 Sponge- and PTEN-mediated decrease in p65/IKKβ/IκB phosphorylation and NFκB transcriptional activity. Furthermore, IKKβ and p65 were required for miR-21-induced renal cancer cell proliferation. Interestingly, miR-21 controlled the expression of cyclin D1 through NFκB-dependent transcription. Finally, we demonstrate that miR-21-regulated renal cancer cell proliferation is mediated by cyclin D1 and CDK4. Together, our results establish a molecular order of a phosphatase-kinase couple involving PTEN/Akt/IKKβ and NFκB-dependent cyclin D1 expression for renal carcinoma cell proliferation by increased miR-21 levels.
authors: Department of Medicine, University of Texas Health Science Center at San Antonio, TX, United States.
authors: Amit
authors: A
authors: Bera
authors: Nandini
authors: N
authors: Ghosh-Choudhury
authors: Nirmalya
authors: N
authors: Dey
authors: Falguni
authors: F
authors: Das
authors: Balakuntalam S
authors: BS
authors: Kasinath
authors: Hanna E
authors: HE
authors: Abboud
authors: Goutam Ghosh
authors: GG
authors: Choudhury
mesh_terms: D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000235:genetics* / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D007680:Kidney Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D035683:MicroRNAs / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D015398:Signal Transduction; D015533:Transcriptional Activation
chemical_list: C524940:MIRN21 microRNA, human; D035683:MicroRNAs; D016328:NF-kappa B; D019938:Cyclin D1; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human
keywords: MicroRNA; NFκB; PTEN; Renal cancer
references: J Clin Oncol. 2004 Dec 15;22(24):4991-5004
references: 15611513
references: Genome Res. 2010 May;20(5):589-99
references: 20439436
references: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8
references: 9990064
references: Cell Signal. 2008 Jan;20(1):120-9
references: 17976956
references: J Cell Mol Med. 2009 Jan;13(1):39-53
references: 19175699
references: Nat Rev Mol Cell Biol. 2004 May;5(5):392-401
references: 15122352
references: Hematol Oncol Clin North Am. 2011 Aug;25(4):667-86
references: 21763962
references: Science. 2008 Mar 28;319(5871):1782-4
references: 18369134
references: Eur J Surg Oncol. 2009 Oct;35(10):1119-23
references: 19443172
references: Int J Cancer. 1999 Jun 21;84(3):268-72
references: 10371345
references: J Surg Oncol. 2003 Nov;84(3):166-72
references: 14598361
references: Annu Rev Biochem. 2009;78:769-96
references: 19489733
references: J Biol Chem. 2012 Feb 3;287(6):3808-22
references: 22184110
references: Mod Pathol. 1998 Nov;11(11):1075-81
references: 9831205
references: J Biol Chem. 1999 Oct 22;274(43):30353-6
references: 10521409
references: Cancer Cell. 2012 Oct 16;22(4):438-51
references: 23079655
references: Br J Cancer. 1999 Aug;80(12):2001-7
references: 10471053
references: Nat Rev Immunol. 2008 Nov;8(11):837-48
references: 18927578
references: Eur Urol. 2001 Apr;39(4):478-83
references: 11306890
references: Clin Chem. 2011 Jul;57(7):954-68
references: 21632885
references: Pathol Res Pract. 2011 Feb 15;207(2):104-10
references: 21167650
references: Nat Med. 1995 Dec;1(12):1257-60
references: 7489405
references: Nat Rev Cancer. 2012 Feb 09;12(3):220-6
references: 22318235
references: Croat Med J. 2008 Oct;49(5):608-17
references: 18925694
references: Sci Signal. 2011 Oct 18;4(195):re2
references: 22009150
references: Cancer. 2011 Jan 15;117(2):290-300
references: 20830770
references: Cancer Res. 2000 Jul 15;60(14):3689-95
references: 10919634
references: Nature. 2001 Jun 28;411(6841):1017-21
references: 11429595
references: Genes Dev. 1998 Aug 15;12(16):2469-74
references: 9716400
references: Cancer Res. 1991 Oct 15;51(20):5736-43
references: 1913692
references: Oncogene. 1998 Jun 18;16(24):3215-8
references: 9671402
references: Mol Cancer Ther. 2008 Jun;7(6):1347-54
references: 18566209
references: J Exp Clin Cancer Res. 2008 Oct 19;27:53
references: 18928570
references: Cancer Cell. 2005 Mar;7(3):263-73
references: 15766664
references: Cancer Metastasis Rev. 2010 Dec;29(4):751-9
references: 20922461
references: Arch Ital Urol Androl. 2012 Jun;84(2):53-60
references: 22908772
references: Cell. 2007 Jan 12;128(1):129-39
references: 17218260
references: Cancer Res. 2011 Feb 1;71(3):629-33
references: 21266353
references: Science. 2009 Sep 4;325(5945):1261-5
references: 19729658
references: Curr Opin Nephrol Hypertens. 2009 Jul;18(4):317-23
references: 19424061
references: Am J Surg Pathol. 2010 Jun;34(6):806-15
references: 20431476
references: PLoS One. 2012;7(6):e37366
references: 22685542
references: Nat Rev Cancer. 2006 Mar;6(3):184-92
references: 16453012
references: Nature. 1994 Jun 23;369(6482):669-71
references: 8208295
references: Cell. 2008 May 2;133(3):403-14
references: 18455982
references: EMBO J. 1994 Aug 1;13(15):3487-95
references: 8062825
references: Urology. 2010 Apr;75(4):835-41
references: 20035975
references: Gastroenterology. 2007 Aug;133(2):647-58
references: 17681183
references: Cancer Control. 1999 Nov;6(6):571-579
references: 10756388
references: Nat Genet. 2010 May;42(5):454-8
references: 20400965
references: Sci Signal. 2010 Nov 02;3(146):pe39
references: 21045203
references: J Biol Chem. 2011 Jul 22;286(29):25586-603
references: 21613227
references: Mol Cell Biol. 1999 Aug;19(8):5785-99
references: 10409765
references: Int J Cancer. 2004 Mar 20;109(2):189-93
references: 14750168
references: Annu Rev Biochem. 2010;79:351-79
references: 20533884
references: Cancer Res. 2007 Dec 15;67(24):11668-76
references: 18089796
references: Nature. 2006 May 25;441(7092):431-6
references: 16724054
references: Semin Nephrol. 2012 May;32(3):253-60
references: 22835456
references: Science. 2002 Mar 15;295(5562):2088-91
references: 11872800
references: BMC Med. 2010 Oct 21;8:64
references: 20964835
references: Oncogene. 2001 Jun 28;20(29):3888-96
references: 11439352
references: Nat Rev Cancer. 2011 Jul 07;11(8):558-72
references: 21734724
references: N Engl J Med. 2003 Jun 5;348(23):2285-93
references: 12788992
references: Cancer Res. 2009 Jun 1;69(11):4674-81
references: 19470766
references: Cancer Res. 2006 Mar 1;66(5):2576-83
references: 16510575
references: Int J Oncol. 2009 Jul;35(1):109-14
references: 19513557
references: Mol Biol Cell. 1997 Feb;8(2):287-301
references: 9190208